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Abstract 
Transcranial magnetic stimulation (TMS) has been regarded as a novel technique of neuromodulation 
with applications that span from the treatment of depression or depression related symptoms to the 
mapping of cerebral regions. This review takes an in depth look into the different forms of magnetic 
stimulation including repetitive TMS, theta-burst stimulation, and navigated TMS. The efficacy of these 
different forms of stimulation is addressed as well as comparisons made to current standards being used. 
Potential clinically relevant future applications of TMS are also discussed from the treatment of obsessive 
compulsive disorder to improving motor function after stroke. The purpose of this review is to provide the 
background information needed to better understand the constructive benefits of TMS and provide 
evidence for why it has a viable future in clinical settings.  
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TRANSCRANIAL MAGNETIC 
STIMULATION: 
Introduction 
With advances in technology, surgical 
procedures are becoming more automated and 
pharmaceuticals are increasing in effectiveness 
and specificity. The changing mentality of 
generations opting for more holistic and non-
invasive treatments is putting pressure on the 
medical industry to be innovative and creative in 
finding new ways to go about treating diseases 
and disorders [1-4]. There is also a push from 
the medical industry for more well-developed, 
minimally invasive procedures. This focus is on 
decreasing the length of stay for patients as well 
as costs [5-7]. One form of treatment that is 
gaining attention is transcranial magnetic 
stimulation (TMS). A neuro-modularly method 
of exciting or inhibiting neuronal function with 
magnetic waves within the brain to elicit 
specific, intended results.  
How it Works 
 There are numerous forms of 
neuromodulation but TMS differs from 
transcranial electric stimulation, another form of 
neuromodulation. While transcranial electric 
stimulation excites pyramidal tracts of neurons 
directly, TMS excites neurons trans-synaptically 
[8]. This means that the neuromodulation 
occurring from TMS is happening in the 
synaptic cleft between neurons, affecting 
neurotransmitter release.   
TMS utilizes magnetic fields produced 
via currents running through coils in either a 
circular or a figure of eight pattern. These 
magnetic fields can induce cortical modulation 
through excitation or depression of neurons 
below the application site. Being a non-invasive 
procedure, it is gaining popularity as an 
alternative to current pharmaceutical or invasive 
forms of treatment. It has clinical applications 
ranging from treatment of depression to cortico-
brain mapping with new applications being 
tested and refined [9]. TMS has come a long 
way in the past decades, with the initial 
development being for furthering our   
understanding of how the brain functions [10], it 
has since, expanded to new ways of treating 
diseases previously thought to only be 
manageable by medications [11].  
Two coils are oriented in a figure of 
eight fashion connected to a power source via a 
handle. A transformer charges a capacitor which 
can instantly discharge. Instantaneous discharge 
generates electrical currents flowing through the 
coils in opposing directions of one another. The 
opposing electrical fields generate magnetic 
fields that last for fractions of a second. The 
magnetic fields that are then applied over the 
scalp (figure 1), overlying the cortical area of 
interest where neuronal synapses are altered, 
either depressing or exciting cortical excitability 
depending on the frequency [10, 12].  
 Generally, TMS, is very well tolerated 
with reports of minor discomfort at the site of 
application during treatment being most 
commonly reported [13]. For patients, treatment 
requires nothing beyond their presence and 
patience while the clinician, which can be a 
doctor, psychiatrist, physiologist, nurse 
practitioner, or physician assistant with suitable 
training and certification, applies the magnetic 
field to the intended region of the brain. Patients 
can read, converse, or even nap during 
treatment. The most common and widely 
Figure 1. Simple diagram of how Transcranial 
Magnetic Stimulation works. A source of power (A) 
charges the capacitors (B). The capacitors are then 
able to send pulses of electrical current through the 
coils (C). The coils rest on the scalp (D) and the 
underlying cortical region is targeted (E) [12]. 
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accepted use of TMS is in the treatment of 
depression and/or depression related symptoms 
[10]. A course of treatment for depression 
entails sessions lasting roughly 30-40 minutes, 
can range from 3-6 times a week and span for 
three to six weeks. TMS has been found to be 
especially useful in patients who have had failed 
results from previous pharmaceutical 
intervention [14].  
 Depending on the desired effects of 
treatment, neurons can either be excited or 
depressed by TMS. The focus is to promote 
neuro-modulation in the region of the brain that 
is associated with the symptoms presented. In 
other applications, TMS is being used to depress 
overexcited neurons that can lead to disorders 
such as epilepsy or obsessive-compulsive 
disorder (OCD). 
 Signals originating from the upper 
regions of the cerebrum start in cortical regions 
and spread the signal via action potentials down 
axons, releasing neurotransmitters, and then 
stimulating the next neuron. This applies to 
motor functions such as muscle flexion in the 
distal portion of fingers to stimulation of 
hormone release resulting in trophic effects 
throughout the body. TMS has applications 
beyond motor tract modulation. The treatment of 
depression is an example of neuro-modulation 
that does not result in changes to any motor 
networks.  
 Based on studies of how TMS evokes 
electric potentials, it suggests that TMS 
stimulates the axons of neurons rather than the 
cell body itself. Accumulation of charge 
surrounding the body of the neuron protects it 
from stimulation. Axons have a lower threshold 
needed for activation/ excitation as compared to 
the neuron body. The electric fields produced by 
magnetic stimulation then run parallel to the 
tissue surface [15].  
 
 
 
Different Forms of TMS 
Repetitive TMS  
There are varying forms of TMS that 
can be utilized depending on the type and 
intended outcome of treatment. The most 
common form of TMS is repetitive TMS 
(rTMS). rTMS is currently being used in the 
treatment of depression. The figure-of-eight 
coils generate a magnetic field creating a 
stimulus that will last for a short period of time 
ranging from milliseconds to several seconds 
followed by intermittent periods of no 
stimulation. This oscillation of stimulation to 
rest repeats for the duration of the treatment and 
results in excitation of the neurons in the 
targeted portion of the brain [14, 16].   
First developed in the mid-1980s, 
repetitive TMS has been the most popular 
stimulatory technique for treatment. With 
constant refinement and specialization it is being 
used to treat disorders such as depression, 
psychosis, anxiety, bipolar disorders, 
obsessions/ compulsions, PTSD; neurological 
diseases like Parkinson’s and epilepsy; and 
rehabilitation of motor function after stroke. 
Many applications are still undergoing clinical 
trials to test efficacy but are beyond proof of 
principle [14, 17, 18].  
Theta-Burst TMS  
A more recent form of TMS being 
researched is Theta-Burst Stimulation (TBS), a 
form of TMS similar to rTMS but magnetic 
pulses are applied in bursts of three at 50 Hz 
with intervals of 200ms of 5 Hz between each 
burst. One study measured the effects of three 
types of TBS and the effects of motor evoked 
potentials (MEPs) [19]. The first of the three 
was intermittent TBS (iTBS), characterized by 2 
seconds of theta-bursts repeated every 10 
seconds for 190 seconds total resulting in 600 
pulses being delivered. The second was 
intermediate TBS (imTBS) where 5 seconds of 
TBS signals were administered every 15 seconds 
for 110 seconds again resulting in a total of 600 
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pulses being delivered. The third was continuous 
TBS (cTBS) where a 40 second, uninterrupted 
train of theta-bursts were delivered. Upon 
completion of stimulus, changes in MEP 
amplitude were measured for twenty minutes. A 
single pulse of TMS over a motor tract above 
motor threshold is used to evoke an 
electromygraphy (EMG) response in small hand 
muscles to measure the long-term potentiation 
versus depression of the three TBS patterns. 
There was a statistically significant difference 
(p<0.005) in amplitude of MEP between each 
pattern. imTBS failed to evoke significant 
potentiation or depression of the MEP. cTBS 
suppressed MEPs for the measured twenty-
minute interval after the treatment. Inversely, 
iTBS facilitated MEPs for the measured time 
frame post-application [19]. 
 Based upon findings from increasing 
numbers of studies on safety and efficacy of 
TBS, reported symptoms and side effects are 
comparable to or less than that of rTMS in both 
frequency and severity [20]. A meta-analysis 
study found that in 4,500 recorded sessions of 
TBS one reported case of a seizure occurred 
during treatment. Statistical risk of a seizure 
associated with TBS is about 0.02%. This data is 
equivocal with the statistical risk associated with 
high frequency TMS. In the same meta-analysis 
it was noted that adverse side effects of high 
frequency TMS was around 40% while reported 
adverse effects of TBS were less than 3% [21].  
Low versus high frequency TMS 
 Repetitive TMS can have inhibitory or 
excitatory effects depending upon the frequency 
used. When the frequency of stimulation is low 
(≤1 Hz) neuroinhibitory effects are observed. 
TMS at 0.1 Hz fails to elicit any change in 
cortical excitability but at 0.9 Hz, applied for 15 
minutes, MEP amplitude was decreased by 
nearly 20% and lasted for nearly 15 minutes 
after treatment [22]. Other studies have found 
that low-frequency rTMS can result in 
significant suppression of MEPs that can persist 
for 30 minutes, depressing motor excitability not 
affecting basic motor behavior[23]. On the 
inverse side of this, high-frequency rTMS can 
lead to excitatory effects on MEP[24].   
 Further studies have been completed 
comparing low versus high frequency rTMS and 
the effects it has on cortical excitability. One 
study comparing 1 and 20 Hz rTMS measured 
the differences in cortical excitability. The 
results were congruent with other studies, 1 Hz 
resulted in decrease of cortical excitability while 
20 Hz increased cortical excitability in all tested 
subjects [25].  
CURRENT APPLICATIONS: 
Clinical Efficacy 
With FDA approval of TMS for the 
treatment of depression in 2008 [12] there have 
been numerous studies done testing the safety 
and efficacy. Currently, TMS is used in the 
treatment of major depressive disorder (MDD), a 
common form of depression characterized by 
frequent, recurrent episodes that lead to 
impairment and disability [26]. Standard 
treatment methods for MDD are antidepressant 
intervention but approximately 20-40% of 
patients find no relief in symptoms from 
medications and/ or psychotherapy [27]. It is not 
uncommon for patients with MDD to develop a 
treatment-resistant illness which ultimately leads 
to a need for alternative treatment options. This 
is where TMS has found its first role in clinical 
settings.  
The most commonly targeted cranial region for 
TMS in the treatment of depression has been the 
left and/ or right dorsolateral prefrontal cortex 
(DLPFC), figure 2. It can be located by its 
relative location to the motor area of the 
abductor pollicis brevis [28]. Most trials choose 
this region based on positive results from early 
studies. Imaging studies also show that in 
depressed patients there is decreased blood flow 
to the left prefrontal cortex. After rTMS of this 
area increased blood flow was observed [29]. 
Other studies have also applied low-frequency 
rTMS to the right prefrontal cortex for the 
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inhibitory effects. It is theorized that opposing 
sides of the brain have contrasting function over 
mood and inhibition of the right prefrontal 
cortex can achieve the same antidepressant 
effects as high-frequency application over the 
left prefrontal cortex [30-32]. 
A study completed by (O’Reardon, et 
al.) was aimed specifically at measuring safety 
and efficacy of TMS over the left DLPFC as a 
treatment for MDD, comprised of 301 diagnosed 
MDD patients that did not benefit from prior 
antidepressant treatments. All patients were 
medication free and going through an MDD 
episode of 3 years or less upon entering the 
study. Severity of symptoms were measured on 
the Clinical Global Impressions Severity of 
Illness (CGI-S) score, the 17 and 24-item 
Hamilton Depression Rating Scale (HAMD17), 
and the Montogomery-Asberg Depression 
Rating Scale (MADRS). The 301 patients were 
evenly divided by random assignment between 
two groups, one group set to receive the active 
TMS treatment, while the other group received 
sham treatment. Sham treatment exposes 
participants to the same initial physical 
procedures but the electrical current ceases after 
the initial burst without the knowledge of the 
patient [33].  
Results were measured at two, four, and 
six weeks. Positive changes were observed in 
the active group when compared to the sham 
group at the two-week interval. At four weeks 
there was a statistical difference observed in the 
MADRS (p=.038), HAMD17 (p=.006), 
HAMD24 (p=.012), and CGI-S (p=.009) scores 
favoring active TMS treatment. Trending 
positive results of active treatment continued to 
improve through the six-week evaluation point, 
figure 3. Remission rates were measured across 
all three evaluation points with no statistical 
difference being measured at two or four weeks 
but a significant statistical difference being 
measured at 6 weeks. No serious side effects 
were observed during the study [33].  
A more recent study conducted by 
(Nathan Bakker, et al. 2015) confirmed the 
positive antidepressant effects of the O’Reardon 
study, utilizing rTMS of the dorsomedial 
prefrontal cortex (DMPFC) for major 
depression. In this study, 98 patients underwent 
DMPFC-rTMS. On the Beck Depression 
Inventory-II scale, response/ remission rates 
were 40.6%/29.2% respectively [14]. 
 
 
 
Figure 3. All figures are changes from baseline 
scores during the acute treatment phase.  (A) is 
the change in Montgomery-Asberg Depreesion 
Scale (MADRS). (B) Hamiliton Depression Rating 
Scale (HAMD; 17 Item). (C) HAMD; 24 Item. [33]   
Figure 2. The blue shaded regions depict the dorsolateral 
prefrontal cortex (DLPRC). The region most commonly 
targeted by transcranial magnetic stimulation [32].  
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Alternative Applications 
Brain Mapping 
 One of the most recently FDA approved 
applications of TMS has been the eXimia 
navigated brain stimulation (NBS) system. This 
device delivers biphasic TMS pulses used for 
mapping motor cortices preoperatively to tumor 
resections. Currently this is the only presurgical, 
noninvasive method of stimulation mapping of 
cortical function. The current gold standard for 
mapping cortical function has been 
intraoperative direct cortical stimulation (DCS) 
during craniotomies. The advantage of the 
current DCS method is that it allows for 
localization of sub regions of the primary motor 
cortex in relation to a tumor [34].  
 Preoperative evaluation using MRI of 
patient motor cortices has been unsatisfactory 
due to tumor-related variables. Peritumoral 
edema, anatomical distortions, and changing 
vasculature disrupt spatial resolution imaging 
technology. New advances in TMS coupled with 
three-dimensional magnetic resonance imaging 
have produced new and promising brain 
mapping capabilities. Navigated TMS (nTMS) 
with optical stereotactic navigation is a feasible 
method of mapping the peritumoral region of the 
primary motor cortex.  
 Early nTMS systems were met with 
varying levels of success which limited their 
clinical applicability. More recently, a study 
utilizing the combination of optically tracked 
navigation with TMS was conducted. A main 
advantage of the new system is its improved 
accuracy being able to account for device 
position, distance from cortex, and size and 
shape of the patient’s head. In the study nTMS 
method was used for preoperative mapping in 20 
patients with brain tumors scheduled for tumor 
resection. The goal of the study was to compare 
accuracy of preoperative nTMS against the 
current gold standard method of intraoperative 
DCS. The eXimia NBS system was used to 
calculate strength, location, and direction of 
stimulatory electric fields in cortical tissue. 
Manipulation of placement and orientation of 
the nTMS device allowed for more accurate 
mapping of primary motor cortex hotspots. This 
method had a mean accuracy of 5.7mm [35]. 
Mapping of the tumor and peritumoral region 
was performed at 110% of resting motor 
threshold and 0.25 Hz. Stimulation to the tumor, 
adjacent gyri and the tumor borders was 
performed with increased special density and 
further variation of coil rotation to ensure 
maximally accurate topography. This whole 
process can be completed in 30 minutes or less 
and caused no discomfort for the patients.  
 Surgical planning and tumor resection 
were performed by a surgeon separate from who 
performed preoperative mapping. The operating 
surgeon received no information about the 
nTMS mapped “hotspots” but was informed of 
motor function around the location of the tumor. 
Intraoperative mapping was done by the surgeon 
during surgery. The results of the intraoperative 
mapping of the primary motor cortex “hotspots” 
were imported to the same coordinate system 
that was used with the nTMS. Images of 
intraoperative DCS and nTMS were marked and 
superimposed, figure 4. DCS and nTMS 
mapping data was taken in 17/20 patients. Data 
was not taken for 3 patients due to technical 
errors or DCS not being performed due to 
bleeding.  
 In all but one patient, hotspots were 
located on the same gyrus. Mean distance 
between the nTMS hotspots and the DCS 
hotspots was 7.83± 1.18mm for the motor cortex 
of the abductor pollicis brevis muscle and 
7.07±0.88mm for tibialis anterior muscle. A 
strong negative correlation was observed 
between the number of DCS responses and the 
distance between the nTMS and DCS hotspots. 
More DCS stimulations resulted in more 
accurate hotspot mapping and decreased the 
distance between nTMS and DCS to less than 
5mm mean distance difference.  
 Advantages of TMS are that it is a 
timelier and equally thorough tool for examining 
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motor topography compared to DCS. TMS also 
allows for cortical mapping in patients who are 
not suitable for functional MRI techniques. TMS 
is best utilized for preoperative diagnostics of 
motor function and its accuracy are comparable 
to current gold standards [35].  
 Robotic TMS is another emerging 
technique for brain mapping. Similar to nTMS, 
it allows for reliable and accurate detection of 
the represented motor cortexes for individual 
muscles or muscle groups. An advantage of this 
method is that it can be used to detect brain 
regions that are displaced due to tumor 
formation [36].  
 In addition to the mapping of motor 
regions, TMS can also be used in mapping 
speech centers of the brain. Patients with lesions 
of language centers of the brain were scheduled 
for surgical excision and received mappings via 
nTMS and traditional intraoperative DCS. The 
current method of intraoperative mapping, 
which utilizes an awake surgery approach and is 
only performed in a select subset of patients, has 
been highly reliable and a vast amount of 
information on the variability of cortical 
language representation has been gathered. The 
only other preoperative language mapping 
technique that has been previously utilized has 
been functional magnetic resonance imagining 
(fMRI), however the accuracy of this technique 
has proven to be less than desirable. Since fMRI 
is reliant on blood flow to regions for mapping, 
lesions like gliomas can hamper the accuracy by 
inducing edema and change oxygenation in the 
peritumoral region [37].  
  Results from the Tarapore, et al. 2016 
study on preoperative brain mapping of 
language centers using nTMS demonstrated 
TMS as effective as current DCS methods. 
Advantages associated with preoperative nTMS 
also include improved risk-benefit assessment 
and extend of risk for lesion resection. nTMS 
also benefits patients not suitable for awake 
craniotomies, creating safer surgeries with 
alternatives to intraoperative mapping 
techniques. Preoperative mapping also creates 
possibility for smaller, more targeted 
craniotomies and faster intraoperative mapping. 
Navigated TMS was well tolerated with no 
adverse events reported, demonstrating 
superiority to intraoperative DCS, which can 
elicit seizures during the craniotomies. All 
patients that would be subject to awake 
craniotomies can complete noninvasive 
language center mapping helping to tailor the 
craniotomy size, location, and resection 
trajectory. Results from preoperative nTMS 
should still be confirmed with intraoperative 
DCS [38]. 
Stroke Recovery 
 Improvements in medicine have greatly 
increased the survival rates in patients post 
stroke. Upwards of 70% of patients who survive 
still experience motor impairment one year after 
incidence[39]. Patients who have suffered from 
strokes currently have several treatment options 
available to them. Most of these treatments 
Figure 4. Comparison of nTMS hotspots mapped 
against DCS hotspots for abductor pollicis brevis 
muscle. Red points mark the nTMS hotspots while 
the orange represents the DCS hotspots [35].  
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involve the retraining or stimulation of the 
muscles on the affected side of the body. 
Bilateral movement training and constraint-
induced movement therapy are two treatment 
methods that work to physically retrain muscle 
function and are best utilized as close to the 
stroke incident as possible[40],[41]. Other 
rehabilitation methods involve brain stimulation, 
improving upon neuro-plasticity.  
 Neuromodulation with TMS or 
transcranial direct current stimulation (TDCS) 
are emerging as methods with proof of principle 
benefits in upregulating the excitability in the 
lesioned hemisphere or downregulating 
excitability in the intact hemisphere[42]. TMS, 
as a non-invasive technique, can be used in 
conjunction with our rehabilitation techniques 
and can enhance the effects of training and 
performance motor tasks. These motor tasks can 
include daily tasks which can allow for patients 
to better care for themselves and regain 
functions that would previously have been 
impaired[43]. 
Memory Enhancement 
 A new and rather exciting possible 
application for TMS is in memory enhancement 
and presentation of savant like-skills. Savants 
are commonly associated with individuals with 
autism, specifically Asperger Syndrome, but 
these skills have also been observed post 
traumatic brain injury or encephalitis. It has 
been hypothesized that the skills and abilities 
needed to be able to process information like 
savants are present in everyone but lie dormant 
from chronically processing information 
differently.  
 The cause for presentation of these skills 
is still unknown but research is being done to see 
if these traits can be artificially triggered in 
people who don’t otherwise display exceptional 
talents. Snyder A, et al. 2003 performed small 
scale, sham controlled, study was done using 
rTMS to inhibit neural activity of the cerebral 
cortex in the left anterior temporal lobe and 
savant-skills were artificially produced [44]. 
 During the study a subset of the 
participants saw significant improvement in 
drawing ability, proofreading, and numerosity. 
All results were compared to pre-treatment 
baselines and then recorded during and 
immediately after treatment. All instances of 
induced, savant characteristics diminished over 
time, returning to baseline within an hour after 
completion of rTMS application. No induced 
changes were observed in participants who 
received sham stimulation [44]. 
Associated Risks 
Most patients experienced little to no 
serious side effects associated with TMS. The 
most commonly reported side effects, according 
to multiple clinical studies evaluating the 
efficacy and safety of TMS, was tingling or 
scalp discomfort around the area of application. 
Seizures are listed as a possible side effect 
however multiple large-scale studies have shown 
that the risk is rather insignificant. Since the 
updated safety guidelines in 1998, there have 
been four reported cases of seizures, three of 
which the patients also took medications that 
could increase the likelihood of seizures and the 
fourth may have been a non-epileptic event [16]   
 Patients with cochlear implants, 
aneurysm clips, bullet fragments, or any other 
form of conductive metal objects inserted in 
their brain and are non-removeable or within 
30cm should avoid magnetic stimulation. There 
is an obvious risk in these cases that the 
magnetic fields generated by the coils can either 
disrupt the function of these devices or cause 
displacement resulting in serious injury or death 
[16].  
Short-Term Side Effects 
According to several studies completed, 
most side effects associated with TMS are short 
lasting and quickly dissipate with the completion 
of treatment sessions, rarely lasting longer than 
the hour following treatment. As previously 
mentioned, the most commonly reported side 
effects are mild scalp discomfort at the site of 
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application, headaches, and neck pain that 
alleviate immediately after application ceases 
[45].  
Long-Term Side Effects 
 Studies that have considered potential 
long-term effects have largely been 
inconclusive. There has also been a lack of 
recorded follow up with patients after the 
treatment period ceases. Alterations in 
neuroplasticity are theorized to be the most 
significant long-term side effect. A common 
concern is the potential negative effect of 
repetitive electric stimulation on neural tissue. In 
a 1990 study by Gordon, et al., two epileptic 
patients received stimulation up to 50 Hz to the 
anterior temporal lobe for a period, and then the 
temporal lobes were resected from the patients 
and studied for histological damage. Using light-
microscopy, no damage was observed  [46, 47].   
Previously mentioned was the concern 
of effects on neuroplasticity. The concern is 
electrical stimulus by TMS and the long-term 
potentiation (LTP) generated. This is where the 
repetitive nature of electrical brain stimulation at 
high frequencies can lead to lasting 
physiological changes in behavior conditioning. 
For a patient suffering from MDD and receiving 
TMS treatment, the desired effect is to alter 
neural function and induce lasting changes that 
will alleviate associated symptoms [48].  
 The lack of conclusive evidence to any 
negative long-term side effects of repeated 
electrical stimulation should be taken as positive 
sign for the possibility of further application of 
TMS but should not be taken as final. There are 
still a lot of questions that need to be answered 
about the effects of stimulation on 
neuroplasticity and what changes it could have 
years down the line. Further research into long 
term effects of varying TMS treatments should 
be a source of interest and discussion if TMS is 
to be an effectively wide spread source of 
treatment.  
CONCLUSION: 
Limitations 
While TMS has been shown to be a safe 
and effective form of treatment for depression as 
well as useful tool in brain mapping there are 
still extensive limitations. Current TMS methods 
are only able to effectively target regions on the 
outermost layer of the brain. While the scalp is 
easily permeable to the magnetic fields, the 
intensity of the magnetic fields is greatly 
reduced beyond just a few centimeters. The 
regions of the brain that are most easily targeted 
by TMS lie in the cortical mantle of the brain, 
within 2-3cm of the surface [49]. New and novel 
techniques and improvement in coil technology 
are being produced and tested to target deeper 
regions of the brain, but current methods are 
limited to the outer cranial regions. The area that 
the magnetic field can induce and provoke 
change in is also relatively small, a spatial 
resolution of 0.5-1cm. This limits the ability to 
study contributions of structures such as cortical 
columns [50].  
 Other limitations of TMS are largely 
associated with the side effects of the treatment. 
There have been international guidelines [16] set 
in place that outline parameters for treatment 
frequency and intensity. Treatment within these 
guidelines is proven to be safe and effective but 
not without risk. Seizures and syncope are the 
two most serious side effects reported but 
improvements in treatment protocol is resulting 
in fewer reported incidences. Sensory side 
effects are among the most commonly reported, 
unintended consequences of treatment. These 
include tapping sensations and/ or auditory 
clicks. These sensory side effects are results 
from the rapid change of magnetic fields that 
TMS generates. In studies measuring 
somatosensory or auditory effects these can 
influence and interfere with task performance 
and results [51]. Depending on the location of 
the treatment the intensity of sensory effects can 
change, increased auditory clicking being 
associated with treatment being closer to the 
auditory region of the brain, lessening as 
treatment gets further away and similar results 
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for somatosensory effects. More minor side 
effects such as headaches, neck pain, and scalp 
irritations ranging from mild to moderate are 
associated with TMS and can impact the results 
of studies and treatment due to patients wishes 
to cease treatment.  
 Currently in the United States, the FDA 
has approved the use of TMS for only a small 
number of psychiatric and neurological 
applications. Two TMS devices have been 
approved for the use of treating depression and 
depression related symptoms. In neurological 
applications, Nexstim eXimia Navigated Brain 
System TMS has been approved for brain 
mapping [27].  
Further research 
 While these applications of TMS are 
being widely implemented in clinics across the 
country there are still relatively new and novel 
techniques and just begin to scratch the surface 
of what future applications could be instore. 
Many possible applications are still in the proof 
of principle phase or even unknown. Extensive 
research has been done on the safety and 
efficacy of noninvasive stimulatory treatments 
for depression and brain mapping, however, 
there has been far less research on other 
applications. A search into possible uses for 
TMS yields numerous results that range from 
treatment of psychological disorders like 
obsessive-compulsive disorder (OCD) and 
addiction. Other possibilities include 
applications to better understand  
interconnectedness of neuronal pathways. Most 
studies that have been done or are currently 
being conducted measuring the effectiveness of 
TMS for uses beyond what has been discussed 
are mostly still in the proof of principle stage, 
being conducted with small numbers of 
individuals taking part and no control or sham 
groups to compare against.   
 Areas of research that are gaining 
popularity are related to the use of TMS 
techniques in the treatment of psychological 
disorders. Small scale studies have been done 
testing the efficacy of low-and high- frequency 
rTMS over varying cerebral regions to depress 
obsessive-compulsive symptoms. Since OCD 
has been characterized by hypermetabolism of 
orbitofrontal-striatal circuits, using depolarizing 
magnetic fields can help in decreasing 
symptoms and returning neural function to a 
normalized level. In studies that include double-
blinded sham control groups, no advantage was 
found in active treatment over sham treatment. 
Further research is needed here that accounts for 
careful consideration of regions to target and 
stimulate parameters. Novel stimulation methods 
are also needed, considering the potential effect 
inhibitory or depressive effect that theta-burst 
stimulation could have on OCD associated 
pathways. Other possible uses of TMS, and 
specifically rTMS, as it relates to OCD may 
include modulation of obsessive-compulsive 
symptoms so that brain activity could be 
measured with functional magnetic resonance 
imaging and receptor-binding studies[52].  
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APPENDICIES: 
A. Citations for this review were done using NLM formating.  
B. Feeback received from my reviewer, Dr. Chrisophter Bilbao D.O., included information on a 
push in the medical industry for well developed, minimally invasive procedures. The goals of 
these being to lessen the length of stay and cost for patients. Other information provided was 
insight into current methods of mapping brain tumors and how tumor-related variables can 
complicate this. Other beneficial feedback included better formatting and organizational 
techniques for the review as a whole and encouragement to clarify or better explain certain topcis. 
I gladly accepted the feedback received and used it to help guide the review.  
 
